Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Clinical advances of RNA therapeutics for treatment of neurological and neuromuscular diseases

28 Apr 2022

Abstract excerpt

RNA therapeutics comprise a diverse group of oligonucleotide-based drugs such as antisense oligonucleotides (ASOs), small interfering RNAs (siRNAs), and short hairpin RNAs (shRNAs) that can be designed to selectively interact with drug targets currently undruggable with small molecule-based drugs or monoclonal antibodies. Furthermore, RNA-based therapeutics have the potential to modulate entire disease pathways,...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Neurogenetic and Muscular Disorders Research
Share to RNA Interference and Gene Delivery
Share to RNA regulation and disease

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Source

Identifiers

PMID: 35482908
DOI: 10.1080/15476286.2022.2066334

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 18 Oct 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Clinical advances of RNA therapeutics for treatment of neurological and neuromuscular diseasesPMID 35482908Read ↗

Therapeutic antisense oligonucleotides for movement disordersSemantic proximity Read ↗

Antisense therapies in neurological diseasesSemantic proximity Read ↗

Antisense Oligonucleotide Therapy for the Nervous System: From Bench to Bedside with Emphasis on Pediatric NeurologySemantic proximity Read ↗

Antisense Drugs Make Sense for Neurological DiseasesSemantic proximity Read ↗

Antisense oligonucleotides and other genetic therapies made simpleSemantic proximity Read ↗

RNA therapeutics for neurological diseasesSemantic proximity Read ↗

Emerging Oligonucleotide Therapeutics for Rare Neuromuscular DiseasesSemantic proximity Read ↗

Application of antisense oligonucleotide drugs in amyotrophic lateral sclerosis and Huntington’s diseaseSemantic proximity Read ↗

Oligonucleotide therapeutics in neurodegenerative diseasesSemantic proximity Read ↗

Antisense oligonucleotide therapies for Amyotrophic Lateral Sclerosis: Existing and emerging targetsSemantic proximity Read ↗

RNA-targeted drugs for neuromuscular diseasesSemantic proximity Read ↗

Recent advances in antisense oligonucleotide therapy in genetic neuromuscular diseasesSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.